Search

Perimenopause and Skin: What is Changing and What Can Actually Help

If your skin has started behaving differently in your 40s – drier than it used to be, more prone to pigmentation, less firm, and seemingly less responsive to products that once worked well – there is a biological reason for all of it. And understanding that reason is the starting point for doing something meaningful about it.

Perimenopause, which typically begins between 40 and 52, changes how skin functions at a cellular level. These are not surface-level changes that a new moisturiser will fix. They are structural and biochemical shifts driven by significant hormonal change – one that involves not just oestrogen, but progesterone and testosterone too.

This article explains what is driving each change, which active skincare ingredients have the clinical evidence behind them, and which treatments at Rejuvenation Clinics of Australia address what skincare alone cannot reach..

The hormonal picture in perimenopause – and why it is more complex than you might think

OMost conversations about perimenopausal skin focus on oestrogen. But the hormonal changes of perimenopause involve three sex hormones – oestrogen, progesterone, and testosterone – each with its own timeline and its own effects on skin. Understanding all three gives a clearer picture of why the skin changes so dramatically during this transition, and often in ways that seem contradictory.

Progesterone – the hormone that changes first

In perimenopause, progesterone typically declines earlier and more steeply than oestrogen, and its fluctuations become erratic rather than following a predictable pattern. This creates periods of relative oestrogen dominance even as both hormones are trending downward overall.

Progesterone has several skin-relevant functions that are often overlooked:

  • Collagen and elastin support — Progesterone contributes to collagen production and skin thickness. Falling levels compound the collagen loss driven by declining oestrogen, meaning skin laxity and thinning can begin earlier in perimenopause than many clients expect, even before oestrogen has declined significantly.
  • Sebum and oil balance — Progesterone influences sebaceous gland activity. As levels fluctuate and then fall, some clients notice a transition from oilier skin towards dryness. Others experience paradoxical adult breakouts during the fluctuation phase, when falling progesterone allows the relative effects of androgens on the skin to become more apparent.
  • Water retention and facial volume perception — Progesterone plays a role in fluid balance. Fluctuating levels can cause cyclical puffiness or subtle changes in facial volume that are not structural but may still create the appearance of facial ageing.
  • Barrier function and sensitivity — Lower progesterone levels are associated with a more reactive, easily irritated skin barrier in some clients, increasing dryness and sensitivity alongside, or even before, the barrier changes driven by declining oestrogen.
  • Healing and inflammation — Progesterone has anti-inflammatory properties. As levels decline, healing following skin treatments may be slower, with redness and post-treatment inflammation potentially lasting longer. This is one of the factors our clinical team considers when developing treatment plans and aftercare recommendations.
Progesterone changes often begin earlier than many women realise. During perimenopause, fluctuating progesterone can influence skin quality, sensitivity and healing well before menopause itself, which is why understanding the underlying hormonal changes is essential when developing an effective treatment plan.

Oestrogen – the broader structural driver

Oestrogen plays an active role in several of the biological processes that keep skin healthy and structurally sound. When levels begin to fluctuate during perimenopause and eventually decline, multiple skin functions change simultaneously:

  • Collagen synthesis — Oestrogen stimulates fibroblasts to produce collagen and elastin. Research published in peer-reviewed dermatology literature indicates that skin loses a significant proportion of its collagen in the first years after menopause, with losses continuing at approximately 2% per year thereafter.
  • Hyaluronic acid production — Oestrogen promotes hyaluronic acid synthesis in the dermis, providing both surface hydration and deeper structural water content. Declining oestrogen means declining internal hydration — the kind that no topical moisturiser can fully replicate.
  • Ceramide production — Oestrogen supports ceramide synthesis, which maintains the skin's protective barrier. As ceramide levels fall, the barrier becomes less effective — allowing more moisture to escape and more irritants to penetrate.
  • Melanin regulation — Oestrogen plays a regulatory role in melanin production. Fluctuating levels disrupt this regulation, triggering uneven pigmentation — particularly on the cheeks, upper lip, and forehead — even in women who have not previously experienced significant pigmentation concerns.
  • Antioxidant function — Oestrogen provides a degree of antioxidant protection in skin tissue. As levels fall, oxidative stress increases, accelerating collagen degradation and compounding UV-triggered pigmentation.

Testosterone – a quieter but relevant role

Testosterone declines gradually during perimenopause, though the picture is complicated by the fact that as oestrogen and progesterone fall, the relative effect of testosterone on the skin can become more pronounced even as absolute levels drop. This relative androgenic shift is what drives some of the oil production and congestion changes that clients notice during the transition – particularly the adult breakouts that can appear alongside dryness in other areas.

Lower testosterone also contributes to reduced skin density and firmness over time, compounding the structural laxity driven by oestrogen and progesterone decline. Its effects on skin are generally less acute than the other two hormones during perimenopause, but worth including in the overall clinical picture.

Perimenopausal skin is not responding to one hormonal change. It is responding to three overlapping ones - each with a different timeline and different skin effects. This is why the changes can feel inconsistent and difficult to pin down, and why a one-ingredient skincare solution rarely addresses all of them.

The skin shifts that appear during perimenopause

1. Barrier thinning and increased sensitivity
Driven by declining oestrogen and progesterone, ceramide production falls and the skin barrier becomes less effective at retaining moisture and more reactive to ingredients, temperatures, and environmental triggers that previously caused no response. Products well tolerated at 35 may cause flushing, redness, or irritation at 45. This is not a new skin type – it is a structural barrier change.

2. Dryness that does not respond to standard moisturisers
Perimenopausal dryness involves a reduction in intracellular water – the hydration held within skin cells rather than between them. Surface emollients address transepidermal water loss but do not reach this deeper depletion. Declining oestrogen and progesterone both contribute to this change, which is why a richer cream may help temporarily but does not resolve the underlying issue.

3. Pigmentation that appears or deepens
Fluctuating oestrogen destabilises melanin production. Existing pigmentation may darken; new patches appear, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver and responds differently to treatment than simple sun damage – which is why the approach needs to be carefully matched.

4. Accelerated fine lines, skin laxity, and volume loss
Declining collagen production – driven by falling oestrogen and progesterone – combined with fat pad atrophy in the mid-face, produces lines that deepen faster than in previous decades. Skin laxity becomes more pronounced around the lower face, jowl, and neck. Loss of structural volume in the cheeks and temples creates a hollowed, descended appearance that is structural rather than surface-level.

5. Breakouts alongside dryness
As oestrogen and progesterone fall, the relative influence of androgens on sebaceous glands increases. Some clients experience congestion, clogged pores, or adult breakouts during the erratic fluctuation phase – alongside dry patches elsewhere. Standard acne advice does not apply well here because the skin is simultaneously dehydrated and producing excess sebum in the same or different areas.

6. Slower healing and increased post-treatment redness
The decline of progesterone’s anti-inflammatory and healing support means that skin may be more reactive after treatments and take longer to settle. This is a factor our clinical team considers when planning treatment intensity, intervals, and aftercare – particularly during the earlier stages of the perimenopausal transition when progesterone fluctuations are most erratic.

Why your existing routine may stop working

Most skincare is formulated with assumptions that hold for skin in a relatively stable hormonal environment: functioning barrier, normal sebum production, adequate collagen turnover. When all of those assumptions change at once – driven by three hormones shifting simultaneously – a routine built on them stops delivering.
This is not a product quality issue. It is a biological mismatch. The actives may be correct, but the concentrations may be too low to produce a clinical effect, the delivery mechanism may not reach the right skin depth, or the routine may address one pathway while leaving others unattended.

The most effective perimenopausal skincare addresses multiple biological pathways simultaneously – collagen stimulation, barrier repair, pigmentation regulation, hydration at both molecular weights, and microbiome support – rather than layering single-purpose products that may conflict with each other.

The actives that have clinical relevance for perimenopausal skin

The Rejuvaus skincare range, developed by Dr Garry Cussell, is built around the ingredient categories below. These are not decorative inclusions – they are actives with published clinical relevance to the biological changes perimenopause causes, delivered at concentrations that produce a measurable effect.

Vitamin A (retinaldehyde, encapsulated at 1%)
Vitamin A accelerates cell turnover – addressing the slowed renewal that drives textural change, congestion, and surface unevenness. It stimulates collagen synthesis and regulates melanin production through retinoic acid receptor pathways. At 1%, it is a clinically relevant dose. The encapsulated form releases slowly over 8 to 12 hours, allowing twice-daily use without the irritation period typically associated with vitamin A at this concentration. This matters for perimenopausal skin, which is often more reactive due to the barrier and healing changes described above.

Vitamin B3 (niacinamide, encapsulated at 10%)
At 10%, vitamin B3 inhibits melanosome transfer, reducing pigmentation over time. It supports ceramide synthesis – directly addressing the barrier thinning driven by declining oestrogen and progesterone. It also regulates sebaceous gland activity, relevant for the androgen-driven congestion that can appear during perimenopause. The encapsulated form avoids the surface flushing that free-form niacinamide can produce at this dose in reactive skin.

Vitamin C (5% superfruit extract including Kakadu Plum)

Vitamin C provides antioxidant protection that compensates partially for the loss of oestrogen’s antioxidant function in skin tissue. It supports collagen synthesis and inhibits tyrosinase – reducing the formation of new pigmentation. At a stable, well-formulated concentration, it works alongside vitamins A and B rather than competing with them.

Dual-weight hyaluronic acid

Larger hyaluronic acid molecules work at the skin surface, reducing transepidermal water loss. Smaller molecules penetrate to the intracellular level, addressing the deeper hydration depletion that standard moisturisers do not reach. Both molecular weights are needed for perimenopausal skin specifically, where the dryness operates at more than one level.

Growth factor serums and collagen peptides

Growth factors promote cellular renewal and skin repair. Collagen peptides support the skin’s structural protein matrix. Together, they provide targeted support to the collagen production pathway that declining oestrogen and progesterone have compromised. They are particularly valuable between clinical treatment sessions as a way of extending and maintaining results.

Pre-, pro-, and postbiotic ferments

The skin microbiome shifts during perimenopause as hormonal changes alter the pH environment beneficial bacteria prefer. A destabilised microbiome correlates with increased sensitivity and reactivity. Formulations that include ferments to support microbial balance address this directly rather than simply avoiding triggers.

The Rejuvaus Repair & Refine ABC Serum contains all five categories in a single formulation. AM and PM, suits all skin types including sensitive, and requires no layering. To help clear the barrier, allowing for deeper serum penetration, the Clarify & Renew AHA BHA Serum adds surface renewal and pore clearance. Together: 56 actives, six biological action categories, two daily applications.

See the Rejuvaus skincare range at au.rejuvaus.com

Where skincare ends and clinical treatment begins

Skincare actives work progressively and primarily within the upper layers of the dermis. For many of the structural changes that perimenopause accelerates – significant collagen loss at depth, skin laxity, volume deflation, established pigmentation, crepey texture – topical actives are a maintenance and prevention tool, not a corrective one.
Clinical treatments deliver energy, polynucleotides, or biocompatible materials deeper into the skin than any topical can reach, producing structural changes that build over weeks and months. The most effective approach combines both: actives at home between sessions, clinical treatment to address what actives cannot.

At RCA, we think of skincare and clinical treatment as the same program, not two separate choices. What you do at home between sessions determines how well you respond to treatment, how long results last, and what you need next time. Dr Cussell incorporates skincare recommendations into every treatment plan.

Clinical treatments for perimenopausal skin at Rejuvenation Clinics of Australia

The following treatments are those most commonly recommended for clients experiencing perimenopausal skin changes. The right combination depends on your individual presentation – which is confirmed during consultation.

Collagen loss, fine lines, skin thinning

Actives to prioritise: Vitamin A (1%), growth factors, collagen peptides

Clinical treatments to consider: Bio remodelling, REJURAN®, RF needling, Fotona 4D, CO2 or Erbium laser, Ultraformer

Skin laxity, sagging, jowling

Actives to prioritise: Vitamin A, vitamin C, collagen peptides

Clinical treatments to consider: Ultraformer (HIFU), Fotona 4D, RF needling, volumising treatments

Pigmentation, uneven tone

Actives to prioritise: Vitamin B3 (10%), vitamin A, vitamin C

Clinical treatments to consider: Pico Rejuvenation, Fraxel, IPL Photo Rejuvenation, Deep Rejuvenation Plus

Barrier thinning, sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics, dual-weight HA

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Growth Factor treatments

Dryness, loss of glow

Actives to prioritise: Dual-weight HA, vitamins B and C, growth factors

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Hydrafacial

Congestion, adult breakouts

Actives to prioritise: Vitamin A, vitamin B3, AHA/BHA exfoliation

Clinical treatments to consider: RF needling, Pico Rejuvenation, medical-grade peels, Cutera Laser Genesis, Hydrafacial

Crepey texture around eyes, neck

Actives to prioritise: Vitamin A, growth factors, collagen peptides

Clinical treatments to consider: SmoothEye, REJURAN® Eye, Fotona 4D, Fraxel, CO2 or Erbium laser

Slower healing, post-treatment sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics

Clinical treatments to consider: Lower-intensity treatment sequencing, Phototherapy, growth factor support

SKIN QUALITY TREATMENTS

REJURAN® skin regeneration treatment

Rejuran uses polynucleotides derived from purified salmon DNA to support the skin’s natural repair environment at a cellular level. For perimenopausal skin specifically, it addresses the quality deterioration that oestrogen decline accelerates: skin thinning, fine dehydration lines, loss of elasticity, and crepey texture. REJURAN® Eye (Rejuran I) is a separately formulated option for the delicate periocular area.

Bio remodelling

Bio remodelling works within the deeper layers of the skin to stimulate collagen and elastin production — not by adding volume but by triggering the skin’s own regenerative response. It improves skin quality, laxity, and deep hydration across the face. Particularly effective for clients experiencing the accelerated skin thinning and laxity that characterises the early menopausal transition.

Glow Factor and Growth Factor treatments

RCA’s growth factor treatment range uses naturally occurring and synthetic growth factors to stimulate cellular renewal, improve hydration, and support the skin’s structural repair processes.

Particularly well suited to perimenopausal skin that is experiencing dullness, dehydration, and overall quality decline alongside other concerns.

LASER AND SKIN REJUVENATION

Fraxel laser

Fraxel stimulates skin cell turnover and collagen production across the face. Clinically proven to reduce fine lines, improve skin texture, and address pigmentation and sun damage simultaneously. Well suited to clients experiencing the combined texture and pigmentation changes that perimenopause accelerates. Involves a few days of redness. 

Pico Rejuvenation

Ultra-short pulse laser technology targeting pigmentation, skin rejuvenation, and uneven tone.

Particularly effective for the hormonally driven pigmentation changes common in perimenopause, with minimal downtime.

CO2 and Erbium laser resurfacing

For clients with more established fine lines, crepey skin texture, or significant cumulative sun damage, laser resurfacing produces meaningful structural change. CO2 delivers the most significant result but requires approximately one week of recovery per session. Full Erbium laser resurfacing offers a similar level of downtime with a gentler heat profile. For those wanting a lighter entry point, the Erbium Peel is a less intensive version that produces gradual improvement with less disruption to the skin surface – though multiple sessions are typically required. All three are available at Sydney CBD. .

Cutera Laser Genesis

A non-ablative treatment for skin quality, redness, enlarged pores, and overall texture refinement. No downtime. Particularly useful for the diffuse redness and skin quality decline that perimenopausal barrier changes can cause. Available at Sydney CBD. At Chatswood, Deep Rejuvenation using Fotona Frac3 delivers a comparable result for skin quality and texture refinement.

SKIN TIGHTENING AND LIFTING

Ultraformer – HIFU skin tightening

High-intensity focused ultrasound delivered to precise depths within the skin and underlying facial tissue – stimulating collagen and producing a meaningful lift and tightening effect that develops over two to three months and can last up to 18 months. Best suited to clients with visible laxity in the lower face, jowls, brow, and neck. A core treatment for the structural laxity that accelerates during perimenopause as oestrogen and progesterone decline.

RF Needling (Vivace and Fraxis Secret RF)

Combines microneedling with radiofrequency energy delivered simultaneously into the dermis, stimulating collagen and elastin production with progressive tightening that develops over two to three months. Addresses surface crepiness, early laxity, texture, and skin quality in the mid-to-lower face. Vivace available at Sydney CBD; Fraxis Secret RF at Chatswood.

Fotona 4D

A four-stage laser treatment that tightens, lifts, smooths, and rejuvenates in a single session by delivering energy both externally and internally via the oral mucosa. Stimulates collagen at multiple depths simultaneously. Effective for clients with visible laxity, deeper lines, and a tired or hollowed appearance — all common presentations in perimenopause. No downtime.

COSMETIC AESTHETICS

Volumising treatments

Volume loss from the mid-face fat pads is a direct consequence of the hormonal and structural changes of perimenopause.

Restoring lost volume with cosmetic aesthetic volumising treatments supports the facial architecture, reduces the appearance of descent-related lines, and creates a more rested and lifted appearance. All cosmetic aesthetic treatments at RCA are performed or supervised by our medical team, trained by Dr Cussell.

Wrinkle relaxing consultations

For expression lines driven by muscle movement – forehead lines, frown lines, crow’s feet – cosmetic aesthetic wrinkle relaxing consultations soften the appearance while preserving natural expression. Often combined with skin quality treatments for a more comprehensive result.

A note on maintenance – why consistency matters more in perimenopause

The ageing process does not pause between clinical treatment sessions. During perimenopause specifically, when the rate of collagen loss accelerates and oestrogen’s protective functions are withdrawing, the period between treatments matters more than it did in your 30s.

This is the argument for a maintenance mindset rather than a reactive one. Clients who combine consistent daily skincare with regular clinical treatment sessions – typically three times per year as a baseline – are maintaining a foundation that means each treatment session holds longer and requires less intervention to achieve the same result.

The alternative – treating when something becomes noticeably worse and then returning to a maintenance gap – means each subsequent session is correcting more lost ground rather than sustaining a plateau.

Dr Cussell’s approach at RCA is to help every client understand the maintenance trajectory from the beginning: what a course of treatment achieves, what sustains it, and what a realistic year of care looks like.

When to start – and why earlier is easier

The perimenopausal transition typically begins several years before the last menstrual period – often in the early-to-mid 40s. Progesterone begins declining before oestrogen, which means skin changes can start appearing earlier than many women expect – sometimes before cycle irregularity or other perimenopausal symptoms become obvious.
Clients who begin addressing perimenopausal skin changes early – before collagen loss, laxity, and pigmentation become established – can achieve meaningful results with a lighter programme and maintain them more easily. Those who come later can still achieve excellent outcomes, but the initial investment in correction is typically greater.
There is no universal right time. The right time is when the concern starts to affect your confidence and you are ready to have a conversation about what is driving it.

Frequently asked questions

What is the difference between perimenopause and menopause skin changes?
Perimenopause refers to the transition period before menopause – typically several years – when oestrogen, progesterone, and testosterone all begin to shift. Progesterone typically declines first and most erratically, which is why some skin changes begin before oestrogen decline becomes the dominant factor. Menopause is defined as 12 months after the final period, with post-menopause referring to the years that follow. Collagen loss accelerates significantly in the early post-menopausal period. Clinically, the approach to skin care is similar across both stages but is adjusted based on the degree of change and the specific concerns presenting.

Why has my skin become so sensitive when it never used to be?
Both oestrogen and progesterone support the skin barrier – oestrogen through ceramide synthesis, progesterone through its anti-inflammatory properties. As both decline and fluctuate, barrier integrity reduces and the skin becomes more reactive to ingredients, temperature changes, and environmental factors. This is a structural change, not a new skin type. The approach is to restore barrier function through targeted actives – ceramides, vitamin B3, pre and postbiotics – and to select clinical treatments that support rather than compromise the barrier while it is in transition.

I am getting pigmentation for the first time – is this related to perimenopause?
Yes. Oestrogen regulates melanin production. Fluctuating levels during perimenopause can trigger uneven melanin stimulation, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver that standard sun-damage treatments may not address fully. Vitamin A accelerates cell turnover to bring pigmented cells to the surface faster; vitamin B3 inhibits the transfer of melanin from melanocytes to surrounding skin cells; Pico laser and Fraxel target pigmentation at depth. Your clinician will assess the type of pigmentation and recommend the most appropriate approach.

I am breaking out but also dry – is that normal during perimenopause?
Yes, and it is one of the more confusing presentations of perimenopausal skin. As oestrogen and progesterone decline, the relative androgenic effect on sebaceous glands increases – which can drive congestion and breakouts in some areas while the skin is simultaneously losing moisture and barrier function in others. This is why standard acne advice and standard dry-skin advice both fall short for perimenopausal skin. The right approach addresses both pathways at once – which is exactly what a clinical assessment at RCA will do.

Can cosmetic treatments help with the structural changes of perimenopause?
Yes – and for structural changes like collagen loss, laxity, and volume deflation, clinical treatments are the only interventions that reach the depth where these changes are occurring. Skincare actives support and maintain; clinical treatments correct and rebuild. The most effective approach combines both.

How many treatments will I need and how often?
This depends on the degree of concern and which treatments are recommended. Most skin quality treatments (REJURAN®, bio remodelling, Glow Factor) involve an initial course of two to three sessions followed by maintenance two to four times per year. Laser resurfacing typically involves a course of three sessions. HIFU skin tightening with Ultraformer is usually one to two sessions per year. Your clinician will give you a realistic course and maintenance plan during your consultation.

Is there anything I should be doing at home between sessions?
Yes – this is a significant part of the overall programme. The right skincare actives used consistently between sessions extend results, prepare the skin for treatment, and slow the rate of change between visits. Dr Cussell recommends a daily routine built around vitamin A, vitamin B3, vitamin C, dual-weight hydration, and growth factor support. For clients managing perimenopausal pigmentation specifically, a pigment inhibiting serum used between laser or skin rejuvenation sessions helps suppress melanin activity and maintain the clarity achieved in clinic. The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

Book your consultation at Rejuvenation Clinics of Australia

If your skin has changed during your 40s and you are not sure what is driving it or what to do about it, a consultation at RCA is the clearest starting point. Dr Garry Cussell and our clinical team – all trained by Dr Cussell directly – take a whole-face, whole-skin approach to every assessment. We will explain what is causing your specific concerns, what combination of actives and treatments is most likely to help, and what a realistic program of care looks like.

Your consultation is complimentary and completely obligation-free.

Book your complimentary consultation today.

Book online: rejuvaustralia.com.au/book-now/
Call us: 1300 88 99 35
Locations: Sydney CBD (254 George Street) | Chatswood (Suite 101, 443 Victoria Avenue)

Individual results vary. Treatment suitability is confirmed during consultation. All content produced in accordance with TGA advertising guidelines. Rejuvenation Clinics of Australia is a doctor-led cosmetic medicine clinic operating in Sydney since 2000. For information about skincare products, visit au.rejuvaus.com.

Book An Obligation-Free Consultation Today

We are located in Sydney CBD and Chatswood.

Note:
The content & media published on our website is for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Any surgical or invasive procedure carries risks, and results of cosmetic procedures will vary.

Read More

Contact Our Team

Get in touch with us through our simple and secure online contact form. Whether you have questions, need more information, or want to schedule a consultation, we’re here to assist you every step of the way.

If your skin has started behaving differently in your 40s – drier than it used to be, more prone to pigmentation, less firm, and seemingly less responsive to products that once worked well – there is a biological reason for all of it. And understanding that reason is the starting point for doing something meaningful about it.

Perimenopause, which typically begins between 40 and 52, changes how skin functions at a cellular level. These are not surface-level changes that a new moisturiser will fix. They are structural and biochemical shifts driven by significant hormonal change – one that involves not just oestrogen, but progesterone and testosterone too.

This article explains what is driving each change, which active skincare ingredients have the clinical evidence behind them, and which treatments at Rejuvenation Clinics of Australia address what skincare alone cannot reach..

The hormonal picture in perimenopause – and why it is more complex than you might think

OMost conversations about perimenopausal skin focus on oestrogen. But the hormonal changes of perimenopause involve three sex hormones – oestrogen, progesterone, and testosterone – each with its own timeline and its own effects on skin. Understanding all three gives a clearer picture of why the skin changes so dramatically during this transition, and often in ways that seem contradictory.

Progesterone – the hormone that changes first

In perimenopause, progesterone typically declines earlier and more steeply than oestrogen, and its fluctuations become erratic rather than following a predictable pattern. This creates periods of relative oestrogen dominance even as both hormones are trending downward overall.

Progesterone has several skin-relevant functions that are often overlooked:

  • Collagen and elastin support — Progesterone contributes to collagen production and skin thickness. Falling levels compound the collagen loss driven by declining oestrogen, meaning skin laxity and thinning can begin earlier in perimenopause than many clients expect, even before oestrogen has declined significantly.
  • Sebum and oil balance — Progesterone influences sebaceous gland activity. As levels fluctuate and then fall, some clients notice a transition from oilier skin towards dryness. Others experience paradoxical adult breakouts during the fluctuation phase, when falling progesterone allows the relative effects of androgens on the skin to become more apparent.
  • Water retention and facial volume perception — Progesterone plays a role in fluid balance. Fluctuating levels can cause cyclical puffiness or subtle changes in facial volume that are not structural but may still create the appearance of facial ageing.
  • Barrier function and sensitivity — Lower progesterone levels are associated with a more reactive, easily irritated skin barrier in some clients, increasing dryness and sensitivity alongside, or even before, the barrier changes driven by declining oestrogen.
  • Healing and inflammation — Progesterone has anti-inflammatory properties. As levels decline, healing following skin treatments may be slower, with redness and post-treatment inflammation potentially lasting longer. This is one of the factors our clinical team considers when developing treatment plans and aftercare recommendations.
Progesterone changes often begin earlier than many women realise. During perimenopause, fluctuating progesterone can influence skin quality, sensitivity and healing well before menopause itself, which is why understanding the underlying hormonal changes is essential when developing an effective treatment plan.

Oestrogen – the broader structural driver

Oestrogen plays an active role in several of the biological processes that keep skin healthy and structurally sound. When levels begin to fluctuate during perimenopause and eventually decline, multiple skin functions change simultaneously:

  • Collagen synthesis — Oestrogen stimulates fibroblasts to produce collagen and elastin. Research published in peer-reviewed dermatology literature indicates that skin loses a significant proportion of its collagen in the first years after menopause, with losses continuing at approximately 2% per year thereafter.
  • Hyaluronic acid production — Oestrogen promotes hyaluronic acid synthesis in the dermis, providing both surface hydration and deeper structural water content. Declining oestrogen means declining internal hydration — the kind that no topical moisturiser can fully replicate.
  • Ceramide production — Oestrogen supports ceramide synthesis, which maintains the skin's protective barrier. As ceramide levels fall, the barrier becomes less effective — allowing more moisture to escape and more irritants to penetrate.
  • Melanin regulation — Oestrogen plays a regulatory role in melanin production. Fluctuating levels disrupt this regulation, triggering uneven pigmentation — particularly on the cheeks, upper lip, and forehead — even in women who have not previously experienced significant pigmentation concerns.
  • Antioxidant function — Oestrogen provides a degree of antioxidant protection in skin tissue. As levels fall, oxidative stress increases, accelerating collagen degradation and compounding UV-triggered pigmentation.

Testosterone – a quieter but relevant role

Testosterone declines gradually during perimenopause, though the picture is complicated by the fact that as oestrogen and progesterone fall, the relative effect of testosterone on the skin can become more pronounced even as absolute levels drop. This relative androgenic shift is what drives some of the oil production and congestion changes that clients notice during the transition – particularly the adult breakouts that can appear alongside dryness in other areas.

Lower testosterone also contributes to reduced skin density and firmness over time, compounding the structural laxity driven by oestrogen and progesterone decline. Its effects on skin are generally less acute than the other two hormones during perimenopause, but worth including in the overall clinical picture.

Perimenopausal skin is not responding to one hormonal change. It is responding to three overlapping ones - each with a different timeline and different skin effects. This is why the changes can feel inconsistent and difficult to pin down, and why a one-ingredient skincare solution rarely addresses all of them.

The skin shifts that appear during perimenopause

1. Barrier thinning and increased sensitivity
Driven by declining oestrogen and progesterone, ceramide production falls and the skin barrier becomes less effective at retaining moisture and more reactive to ingredients, temperatures, and environmental triggers that previously caused no response. Products well tolerated at 35 may cause flushing, redness, or irritation at 45. This is not a new skin type – it is a structural barrier change.

2. Dryness that does not respond to standard moisturisers
Perimenopausal dryness involves a reduction in intracellular water – the hydration held within skin cells rather than between them. Surface emollients address transepidermal water loss but do not reach this deeper depletion. Declining oestrogen and progesterone both contribute to this change, which is why a richer cream may help temporarily but does not resolve the underlying issue.

3. Pigmentation that appears or deepens
Fluctuating oestrogen destabilises melanin production. Existing pigmentation may darken; new patches appear, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver and responds differently to treatment than simple sun damage – which is why the approach needs to be carefully matched.

4. Accelerated fine lines, skin laxity, and volume loss
Declining collagen production – driven by falling oestrogen and progesterone – combined with fat pad atrophy in the mid-face, produces lines that deepen faster than in previous decades. Skin laxity becomes more pronounced around the lower face, jowl, and neck. Loss of structural volume in the cheeks and temples creates a hollowed, descended appearance that is structural rather than surface-level.

5. Breakouts alongside dryness
As oestrogen and progesterone fall, the relative influence of androgens on sebaceous glands increases. Some clients experience congestion, clogged pores, or adult breakouts during the erratic fluctuation phase – alongside dry patches elsewhere. Standard acne advice does not apply well here because the skin is simultaneously dehydrated and producing excess sebum in the same or different areas.

6. Slower healing and increased post-treatment redness
The decline of progesterone’s anti-inflammatory and healing support means that skin may be more reactive after treatments and take longer to settle. This is a factor our clinical team considers when planning treatment intensity, intervals, and aftercare – particularly during the earlier stages of the perimenopausal transition when progesterone fluctuations are most erratic.

Why your existing routine may stop working

Most skincare is formulated with assumptions that hold for skin in a relatively stable hormonal environment: functioning barrier, normal sebum production, adequate collagen turnover. When all of those assumptions change at once – driven by three hormones shifting simultaneously – a routine built on them stops delivering.
This is not a product quality issue. It is a biological mismatch. The actives may be correct, but the concentrations may be too low to produce a clinical effect, the delivery mechanism may not reach the right skin depth, or the routine may address one pathway while leaving others unattended.

The most effective perimenopausal skincare addresses multiple biological pathways simultaneously – collagen stimulation, barrier repair, pigmentation regulation, hydration at both molecular weights, and microbiome support – rather than layering single-purpose products that may conflict with each other.

The actives that have clinical relevance for perimenopausal skin

The Rejuvaus skincare range, developed by Dr Garry Cussell, is built around the ingredient categories below. These are not decorative inclusions – they are actives with published clinical relevance to the biological changes perimenopause causes, delivered at concentrations that produce a measurable effect.

Vitamin A (retinaldehyde, encapsulated at 1%)
Vitamin A accelerates cell turnover – addressing the slowed renewal that drives textural change, congestion, and surface unevenness. It stimulates collagen synthesis and regulates melanin production through retinoic acid receptor pathways. At 1%, it is a clinically relevant dose. The encapsulated form releases slowly over 8 to 12 hours, allowing twice-daily use without the irritation period typically associated with vitamin A at this concentration. This matters for perimenopausal skin, which is often more reactive due to the barrier and healing changes described above.

Vitamin B3 (niacinamide, encapsulated at 10%)
At 10%, vitamin B3 inhibits melanosome transfer, reducing pigmentation over time. It supports ceramide synthesis – directly addressing the barrier thinning driven by declining oestrogen and progesterone. It also regulates sebaceous gland activity, relevant for the androgen-driven congestion that can appear during perimenopause. The encapsulated form avoids the surface flushing that free-form niacinamide can produce at this dose in reactive skin.

Vitamin C (5% superfruit extract including Kakadu Plum)

Vitamin C provides antioxidant protection that compensates partially for the loss of oestrogen’s antioxidant function in skin tissue. It supports collagen synthesis and inhibits tyrosinase – reducing the formation of new pigmentation. At a stable, well-formulated concentration, it works alongside vitamins A and B rather than competing with them.

Dual-weight hyaluronic acid

Larger hyaluronic acid molecules work at the skin surface, reducing transepidermal water loss. Smaller molecules penetrate to the intracellular level, addressing the deeper hydration depletion that standard moisturisers do not reach. Both molecular weights are needed for perimenopausal skin specifically, where the dryness operates at more than one level.

Growth factor serums and collagen peptides

Growth factors promote cellular renewal and skin repair. Collagen peptides support the skin’s structural protein matrix. Together, they provide targeted support to the collagen production pathway that declining oestrogen and progesterone have compromised. They are particularly valuable between clinical treatment sessions as a way of extending and maintaining results.

Pre-, pro-, and postbiotic ferments

The skin microbiome shifts during perimenopause as hormonal changes alter the pH environment beneficial bacteria prefer. A destabilised microbiome correlates with increased sensitivity and reactivity. Formulations that include ferments to support microbial balance address this directly rather than simply avoiding triggers.

The Rejuvaus Repair & Refine ABC Serum contains all five categories in a single formulation. AM and PM, suits all skin types including sensitive, and requires no layering. To help clear the barrier, allowing for deeper serum penetration, the Clarify & Renew AHA BHA Serum adds surface renewal and pore clearance. Together: 56 actives, six biological action categories, two daily applications.

See the Rejuvaus skincare range at au.rejuvaus.com

Where skincare ends and clinical treatment begins

Skincare actives work progressively and primarily within the upper layers of the dermis. For many of the structural changes that perimenopause accelerates – significant collagen loss at depth, skin laxity, volume deflation, established pigmentation, crepey texture – topical actives are a maintenance and prevention tool, not a corrective one.
Clinical treatments deliver energy, polynucleotides, or biocompatible materials deeper into the skin than any topical can reach, producing structural changes that build over weeks and months. The most effective approach combines both: actives at home between sessions, clinical treatment to address what actives cannot.

At RCA, we think of skincare and clinical treatment as the same program, not two separate choices. What you do at home between sessions determines how well you respond to treatment, how long results last, and what you need next time. Dr Cussell incorporates skincare recommendations into every treatment plan.

Clinical treatments for perimenopausal skin at Rejuvenation Clinics of Australia

The following treatments are those most commonly recommended for clients experiencing perimenopausal skin changes. The right combination depends on your individual presentation – which is confirmed during consultation.

Collagen loss, fine lines, skin thinning

Actives to prioritise: Vitamin A (1%), growth factors, collagen peptides

Clinical treatments to consider: Bio remodelling, REJURAN®, RF needling, Fotona 4D, CO2 or Erbium laser, Ultraformer

Skin laxity, sagging, jowling

Actives to prioritise: Vitamin A, vitamin C, collagen peptides

Clinical treatments to consider: Ultraformer (HIFU), Fotona 4D, RF needling, volumising treatments

Pigmentation, uneven tone

Actives to prioritise: Vitamin B3 (10%), vitamin A, vitamin C

Clinical treatments to consider: Pico Rejuvenation, Fraxel, IPL Photo Rejuvenation, Deep Rejuvenation Plus

Barrier thinning, sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics, dual-weight HA

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Growth Factor treatments

Dryness, loss of glow

Actives to prioritise: Dual-weight HA, vitamins B and C, growth factors

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Hydrafacial

Congestion, adult breakouts

Actives to prioritise: Vitamin A, vitamin B3, AHA/BHA exfoliation

Clinical treatments to consider: RF needling, Pico Rejuvenation, medical-grade peels, Cutera Laser Genesis, Hydrafacial

Crepey texture around eyes, neck

Actives to prioritise: Vitamin A, growth factors, collagen peptides

Clinical treatments to consider: SmoothEye, REJURAN® Eye, Fotona 4D, Fraxel, CO2 or Erbium laser

Slower healing, post-treatment sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics

Clinical treatments to consider: Lower-intensity treatment sequencing, Phototherapy, growth factor support

SKIN QUALITY TREATMENTS

REJURAN® skin regeneration treatment

Rejuran uses polynucleotides derived from purified salmon DNA to support the skin’s natural repair environment at a cellular level. For perimenopausal skin specifically, it addresses the quality deterioration that oestrogen decline accelerates: skin thinning, fine dehydration lines, loss of elasticity, and crepey texture. REJURAN® Eye (Rejuran I) is a separately formulated option for the delicate periocular area.

Bio remodelling

Bio remodelling works within the deeper layers of the skin to stimulate collagen and elastin production — not by adding volume but by triggering the skin’s own regenerative response. It improves skin quality, laxity, and deep hydration across the face. Particularly effective for clients experiencing the accelerated skin thinning and laxity that characterises the early menopausal transition.

Glow Factor and Growth Factor treatments

RCA’s growth factor treatment range uses naturally occurring and synthetic growth factors to stimulate cellular renewal, improve hydration, and support the skin’s structural repair processes.

Particularly well suited to perimenopausal skin that is experiencing dullness, dehydration, and overall quality decline alongside other concerns.

LASER AND SKIN REJUVENATION

Fraxel laser

Fraxel stimulates skin cell turnover and collagen production across the face. Clinically proven to reduce fine lines, improve skin texture, and address pigmentation and sun damage simultaneously. Well suited to clients experiencing the combined texture and pigmentation changes that perimenopause accelerates. Involves a few days of redness. 

Pico Rejuvenation

Ultra-short pulse laser technology targeting pigmentation, skin rejuvenation, and uneven tone.

Particularly effective for the hormonally driven pigmentation changes common in perimenopause, with minimal downtime.

CO2 and Erbium laser resurfacing

For clients with more established fine lines, crepey skin texture, or significant cumulative sun damage, laser resurfacing produces meaningful structural change. CO2 delivers the most significant result but requires approximately one week of recovery per session. Full Erbium laser resurfacing offers a similar level of downtime with a gentler heat profile. For those wanting a lighter entry point, the Erbium Peel is a less intensive version that produces gradual improvement with less disruption to the skin surface – though multiple sessions are typically required. All three are available at Sydney CBD. .

Cutera Laser Genesis

A non-ablative treatment for skin quality, redness, enlarged pores, and overall texture refinement. No downtime. Particularly useful for the diffuse redness and skin quality decline that perimenopausal barrier changes can cause. Available at Sydney CBD. At Chatswood, Deep Rejuvenation using Fotona Frac3 delivers a comparable result for skin quality and texture refinement.

SKIN TIGHTENING AND LIFTING

Ultraformer – HIFU skin tightening

High-intensity focused ultrasound delivered to precise depths within the skin and underlying facial tissue – stimulating collagen and producing a meaningful lift and tightening effect that develops over two to three months and can last up to 18 months. Best suited to clients with visible laxity in the lower face, jowls, brow, and neck. A core treatment for the structural laxity that accelerates during perimenopause as oestrogen and progesterone decline.

RF Needling (Vivace and Fraxis Secret RF)

Combines microneedling with radiofrequency energy delivered simultaneously into the dermis, stimulating collagen and elastin production with progressive tightening that develops over two to three months. Addresses surface crepiness, early laxity, texture, and skin quality in the mid-to-lower face. Vivace available at Sydney CBD; Fraxis Secret RF at Chatswood.

Fotona 4D

A four-stage laser treatment that tightens, lifts, smooths, and rejuvenates in a single session by delivering energy both externally and internally via the oral mucosa. Stimulates collagen at multiple depths simultaneously. Effective for clients with visible laxity, deeper lines, and a tired or hollowed appearance — all common presentations in perimenopause. No downtime.

COSMETIC AESTHETICS

Volumising treatments

Volume loss from the mid-face fat pads is a direct consequence of the hormonal and structural changes of perimenopause.

Restoring lost volume with cosmetic aesthetic volumising treatments supports the facial architecture, reduces the appearance of descent-related lines, and creates a more rested and lifted appearance. All cosmetic aesthetic treatments at RCA are performed or supervised by our medical team, trained by Dr Cussell.

Wrinkle relaxing consultations

For expression lines driven by muscle movement – forehead lines, frown lines, crow’s feet – cosmetic aesthetic wrinkle relaxing consultations soften the appearance while preserving natural expression. Often combined with skin quality treatments for a more comprehensive result.

A note on maintenance – why consistency matters more in perimenopause

The ageing process does not pause between clinical treatment sessions. During perimenopause specifically, when the rate of collagen loss accelerates and oestrogen’s protective functions are withdrawing, the period between treatments matters more than it did in your 30s.

This is the argument for a maintenance mindset rather than a reactive one. Clients who combine consistent daily skincare with regular clinical treatment sessions – typically three times per year as a baseline – are maintaining a foundation that means each treatment session holds longer and requires less intervention to achieve the same result.

The alternative – treating when something becomes noticeably worse and then returning to a maintenance gap – means each subsequent session is correcting more lost ground rather than sustaining a plateau.

Dr Cussell’s approach at RCA is to help every client understand the maintenance trajectory from the beginning: what a course of treatment achieves, what sustains it, and what a realistic year of care looks like.

When to start – and why earlier is easier

The perimenopausal transition typically begins several years before the last menstrual period – often in the early-to-mid 40s. Progesterone begins declining before oestrogen, which means skin changes can start appearing earlier than many women expect – sometimes before cycle irregularity or other perimenopausal symptoms become obvious.
Clients who begin addressing perimenopausal skin changes early – before collagen loss, laxity, and pigmentation become established – can achieve meaningful results with a lighter programme and maintain them more easily. Those who come later can still achieve excellent outcomes, but the initial investment in correction is typically greater.
There is no universal right time. The right time is when the concern starts to affect your confidence and you are ready to have a conversation about what is driving it.

Frequently asked questions

What is the difference between perimenopause and menopause skin changes?
Perimenopause refers to the transition period before menopause – typically several years – when oestrogen, progesterone, and testosterone all begin to shift. Progesterone typically declines first and most erratically, which is why some skin changes begin before oestrogen decline becomes the dominant factor. Menopause is defined as 12 months after the final period, with post-menopause referring to the years that follow. Collagen loss accelerates significantly in the early post-menopausal period. Clinically, the approach to skin care is similar across both stages but is adjusted based on the degree of change and the specific concerns presenting.

Why has my skin become so sensitive when it never used to be?
Both oestrogen and progesterone support the skin barrier – oestrogen through ceramide synthesis, progesterone through its anti-inflammatory properties. As both decline and fluctuate, barrier integrity reduces and the skin becomes more reactive to ingredients, temperature changes, and environmental factors. This is a structural change, not a new skin type. The approach is to restore barrier function through targeted actives – ceramides, vitamin B3, pre and postbiotics – and to select clinical treatments that support rather than compromise the barrier while it is in transition.

I am getting pigmentation for the first time – is this related to perimenopause?
Yes. Oestrogen regulates melanin production. Fluctuating levels during perimenopause can trigger uneven melanin stimulation, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver that standard sun-damage treatments may not address fully. Vitamin A accelerates cell turnover to bring pigmented cells to the surface faster; vitamin B3 inhibits the transfer of melanin from melanocytes to surrounding skin cells; Pico laser and Fraxel target pigmentation at depth. Your clinician will assess the type of pigmentation and recommend the most appropriate approach.

I am breaking out but also dry – is that normal during perimenopause?
Yes, and it is one of the more confusing presentations of perimenopausal skin. As oestrogen and progesterone decline, the relative androgenic effect on sebaceous glands increases – which can drive congestion and breakouts in some areas while the skin is simultaneously losing moisture and barrier function in others. This is why standard acne advice and standard dry-skin advice both fall short for perimenopausal skin. The right approach addresses both pathways at once – which is exactly what a clinical assessment at RCA will do.

Can cosmetic treatments help with the structural changes of perimenopause?
Yes – and for structural changes like collagen loss, laxity, and volume deflation, clinical treatments are the only interventions that reach the depth where these changes are occurring. Skincare actives support and maintain; clinical treatments correct and rebuild. The most effective approach combines both.

How many treatments will I need and how often?
This depends on the degree of concern and which treatments are recommended. Most skin quality treatments (REJURAN®, bio remodelling, Glow Factor) involve an initial course of two to three sessions followed by maintenance two to four times per year. Laser resurfacing typically involves a course of three sessions. HIFU skin tightening with Ultraformer is usually one to two sessions per year. Your clinician will give you a realistic course and maintenance plan during your consultation.

Is there anything I should be doing at home between sessions?
Yes – this is a significant part of the overall programme. The right skincare actives used consistently between sessions extend results, prepare the skin for treatment, and slow the rate of change between visits. Dr Cussell recommends a daily routine built around vitamin A, vitamin B3, vitamin C, dual-weight hydration, and growth factor support. For clients managing perimenopausal pigmentation specifically, a pigment inhibiting serum used between laser or skin rejuvenation sessions helps suppress melanin activity and maintain the clarity achieved in clinic. The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

Book your consultation at Rejuvenation Clinics of Australia

If your skin has changed during your 40s and you are not sure what is driving it or what to do about it, a consultation at RCA is the clearest starting point. Dr Garry Cussell and our clinical team – all trained by Dr Cussell directly – take a whole-face, whole-skin approach to every assessment. We will explain what is causing your specific concerns, what combination of actives and treatments is most likely to help, and what a realistic program of care looks like.

Your consultation is complimentary and completely obligation-free.

Book your complimentary consultation today.

Book online: rejuvaustralia.com.au/book-now/
Call us: 1300 88 99 35
Locations: Sydney CBD (254 George Street) | Chatswood (Suite 101, 443 Victoria Avenue)

Individual results vary. Treatment suitability is confirmed during consultation. All content produced in accordance with TGA advertising guidelines. Rejuvenation Clinics of Australia is a doctor-led cosmetic medicine clinic operating in Sydney since 2000. For information about skincare products, visit au.rejuvaus.com.

If your skin has started behaving differently in your 40s – drier than it used to be, more prone to pigmentation, less firm, and seemingly less responsive to products that once worked well – there is a biological reason for all of it. And understanding that reason is the starting point for doing something meaningful about it.

Perimenopause, which typically begins between 40 and 52, changes how skin functions at a cellular level. These are not surface-level changes that a new moisturiser will fix. They are structural and biochemical shifts driven by significant hormonal change – one that involves not just oestrogen, but progesterone and testosterone too.

This article explains what is driving each change, which active skincare ingredients have the clinical evidence behind them, and which treatments at Rejuvenation Clinics of Australia address what skincare alone cannot reach..

The hormonal picture in perimenopause – and why it is more complex than you might think

OMost conversations about perimenopausal skin focus on oestrogen. But the hormonal changes of perimenopause involve three sex hormones – oestrogen, progesterone, and testosterone – each with its own timeline and its own effects on skin. Understanding all three gives a clearer picture of why the skin changes so dramatically during this transition, and often in ways that seem contradictory.

Progesterone – the hormone that changes first

In perimenopause, progesterone typically declines earlier and more steeply than oestrogen, and its fluctuations become erratic rather than following a predictable pattern. This creates periods of relative oestrogen dominance even as both hormones are trending downward overall.

Progesterone has several skin-relevant functions that are often overlooked:

  • Collagen and elastin support — Progesterone contributes to collagen production and skin thickness. Falling levels compound the collagen loss driven by declining oestrogen, meaning skin laxity and thinning can begin earlier in perimenopause than many clients expect, even before oestrogen has declined significantly.
  • Sebum and oil balance — Progesterone influences sebaceous gland activity. As levels fluctuate and then fall, some clients notice a transition from oilier skin towards dryness. Others experience paradoxical adult breakouts during the fluctuation phase, when falling progesterone allows the relative effects of androgens on the skin to become more apparent.
  • Water retention and facial volume perception — Progesterone plays a role in fluid balance. Fluctuating levels can cause cyclical puffiness or subtle changes in facial volume that are not structural but may still create the appearance of facial ageing.
  • Barrier function and sensitivity — Lower progesterone levels are associated with a more reactive, easily irritated skin barrier in some clients, increasing dryness and sensitivity alongside, or even before, the barrier changes driven by declining oestrogen.
  • Healing and inflammation — Progesterone has anti-inflammatory properties. As levels decline, healing following skin treatments may be slower, with redness and post-treatment inflammation potentially lasting longer. This is one of the factors our clinical team considers when developing treatment plans and aftercare recommendations.
Progesterone changes often begin earlier than many women realise. During perimenopause, fluctuating progesterone can influence skin quality, sensitivity and healing well before menopause itself, which is why understanding the underlying hormonal changes is essential when developing an effective treatment plan.

Oestrogen – the broader structural driver

Oestrogen plays an active role in several of the biological processes that keep skin healthy and structurally sound. When levels begin to fluctuate during perimenopause and eventually decline, multiple skin functions change simultaneously:

  • Collagen synthesis — Oestrogen stimulates fibroblasts to produce collagen and elastin. Research published in peer-reviewed dermatology literature indicates that skin loses a significant proportion of its collagen in the first years after menopause, with losses continuing at approximately 2% per year thereafter.
  • Hyaluronic acid production — Oestrogen promotes hyaluronic acid synthesis in the dermis, providing both surface hydration and deeper structural water content. Declining oestrogen means declining internal hydration — the kind that no topical moisturiser can fully replicate.
  • Ceramide production — Oestrogen supports ceramide synthesis, which maintains the skin's protective barrier. As ceramide levels fall, the barrier becomes less effective — allowing more moisture to escape and more irritants to penetrate.
  • Melanin regulation — Oestrogen plays a regulatory role in melanin production. Fluctuating levels disrupt this regulation, triggering uneven pigmentation — particularly on the cheeks, upper lip, and forehead — even in women who have not previously experienced significant pigmentation concerns.
  • Antioxidant function — Oestrogen provides a degree of antioxidant protection in skin tissue. As levels fall, oxidative stress increases, accelerating collagen degradation and compounding UV-triggered pigmentation.

Testosterone – a quieter but relevant role

Testosterone declines gradually during perimenopause, though the picture is complicated by the fact that as oestrogen and progesterone fall, the relative effect of testosterone on the skin can become more pronounced even as absolute levels drop. This relative androgenic shift is what drives some of the oil production and congestion changes that clients notice during the transition – particularly the adult breakouts that can appear alongside dryness in other areas.

Lower testosterone also contributes to reduced skin density and firmness over time, compounding the structural laxity driven by oestrogen and progesterone decline. Its effects on skin are generally less acute than the other two hormones during perimenopause, but worth including in the overall clinical picture.

Perimenopausal skin is not responding to one hormonal change. It is responding to three overlapping ones - each with a different timeline and different skin effects. This is why the changes can feel inconsistent and difficult to pin down, and why a one-ingredient skincare solution rarely addresses all of them.

The skin shifts that appear during perimenopause

1. Barrier thinning and increased sensitivity
Driven by declining oestrogen and progesterone, ceramide production falls and the skin barrier becomes less effective at retaining moisture and more reactive to ingredients, temperatures, and environmental triggers that previously caused no response. Products well tolerated at 35 may cause flushing, redness, or irritation at 45. This is not a new skin type – it is a structural barrier change.

2. Dryness that does not respond to standard moisturisers
Perimenopausal dryness involves a reduction in intracellular water – the hydration held within skin cells rather than between them. Surface emollients address transepidermal water loss but do not reach this deeper depletion. Declining oestrogen and progesterone both contribute to this change, which is why a richer cream may help temporarily but does not resolve the underlying issue.

3. Pigmentation that appears or deepens
Fluctuating oestrogen destabilises melanin production. Existing pigmentation may darken; new patches appear, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver and responds differently to treatment than simple sun damage – which is why the approach needs to be carefully matched.

4. Accelerated fine lines, skin laxity, and volume loss
Declining collagen production – driven by falling oestrogen and progesterone – combined with fat pad atrophy in the mid-face, produces lines that deepen faster than in previous decades. Skin laxity becomes more pronounced around the lower face, jowl, and neck. Loss of structural volume in the cheeks and temples creates a hollowed, descended appearance that is structural rather than surface-level.

5. Breakouts alongside dryness
As oestrogen and progesterone fall, the relative influence of androgens on sebaceous glands increases. Some clients experience congestion, clogged pores, or adult breakouts during the erratic fluctuation phase – alongside dry patches elsewhere. Standard acne advice does not apply well here because the skin is simultaneously dehydrated and producing excess sebum in the same or different areas.

6. Slower healing and increased post-treatment redness
The decline of progesterone’s anti-inflammatory and healing support means that skin may be more reactive after treatments and take longer to settle. This is a factor our clinical team considers when planning treatment intensity, intervals, and aftercare – particularly during the earlier stages of the perimenopausal transition when progesterone fluctuations are most erratic.

Why your existing routine may stop working

Most skincare is formulated with assumptions that hold for skin in a relatively stable hormonal environment: functioning barrier, normal sebum production, adequate collagen turnover. When all of those assumptions change at once – driven by three hormones shifting simultaneously – a routine built on them stops delivering.
This is not a product quality issue. It is a biological mismatch. The actives may be correct, but the concentrations may be too low to produce a clinical effect, the delivery mechanism may not reach the right skin depth, or the routine may address one pathway while leaving others unattended.

The most effective perimenopausal skincare addresses multiple biological pathways simultaneously – collagen stimulation, barrier repair, pigmentation regulation, hydration at both molecular weights, and microbiome support – rather than layering single-purpose products that may conflict with each other.

The actives that have clinical relevance for perimenopausal skin

The Rejuvaus skincare range, developed by Dr Garry Cussell, is built around the ingredient categories below. These are not decorative inclusions – they are actives with published clinical relevance to the biological changes perimenopause causes, delivered at concentrations that produce a measurable effect.

Vitamin A (retinaldehyde, encapsulated at 1%)
Vitamin A accelerates cell turnover – addressing the slowed renewal that drives textural change, congestion, and surface unevenness. It stimulates collagen synthesis and regulates melanin production through retinoic acid receptor pathways. At 1%, it is a clinically relevant dose. The encapsulated form releases slowly over 8 to 12 hours, allowing twice-daily use without the irritation period typically associated with vitamin A at this concentration. This matters for perimenopausal skin, which is often more reactive due to the barrier and healing changes described above.

Vitamin B3 (niacinamide, encapsulated at 10%)
At 10%, vitamin B3 inhibits melanosome transfer, reducing pigmentation over time. It supports ceramide synthesis – directly addressing the barrier thinning driven by declining oestrogen and progesterone. It also regulates sebaceous gland activity, relevant for the androgen-driven congestion that can appear during perimenopause. The encapsulated form avoids the surface flushing that free-form niacinamide can produce at this dose in reactive skin.

Vitamin C (5% superfruit extract including Kakadu Plum)

Vitamin C provides antioxidant protection that compensates partially for the loss of oestrogen’s antioxidant function in skin tissue. It supports collagen synthesis and inhibits tyrosinase – reducing the formation of new pigmentation. At a stable, well-formulated concentration, it works alongside vitamins A and B rather than competing with them.

Dual-weight hyaluronic acid

Larger hyaluronic acid molecules work at the skin surface, reducing transepidermal water loss. Smaller molecules penetrate to the intracellular level, addressing the deeper hydration depletion that standard moisturisers do not reach. Both molecular weights are needed for perimenopausal skin specifically, where the dryness operates at more than one level.

Growth factor serums and collagen peptides

Growth factors promote cellular renewal and skin repair. Collagen peptides support the skin’s structural protein matrix. Together, they provide targeted support to the collagen production pathway that declining oestrogen and progesterone have compromised. They are particularly valuable between clinical treatment sessions as a way of extending and maintaining results.

Pre-, pro-, and postbiotic ferments

The skin microbiome shifts during perimenopause as hormonal changes alter the pH environment beneficial bacteria prefer. A destabilised microbiome correlates with increased sensitivity and reactivity. Formulations that include ferments to support microbial balance address this directly rather than simply avoiding triggers.

The Rejuvaus Repair & Refine ABC Serum contains all five categories in a single formulation. AM and PM, suits all skin types including sensitive, and requires no layering. To help clear the barrier, allowing for deeper serum penetration, the Clarify & Renew AHA BHA Serum adds surface renewal and pore clearance. Together: 56 actives, six biological action categories, two daily applications.

See the Rejuvaus skincare range at au.rejuvaus.com

Where skincare ends and clinical treatment begins

Skincare actives work progressively and primarily within the upper layers of the dermis. For many of the structural changes that perimenopause accelerates – significant collagen loss at depth, skin laxity, volume deflation, established pigmentation, crepey texture – topical actives are a maintenance and prevention tool, not a corrective one.
Clinical treatments deliver energy, polynucleotides, or biocompatible materials deeper into the skin than any topical can reach, producing structural changes that build over weeks and months. The most effective approach combines both: actives at home between sessions, clinical treatment to address what actives cannot.

At RCA, we think of skincare and clinical treatment as the same program, not two separate choices. What you do at home between sessions determines how well you respond to treatment, how long results last, and what you need next time. Dr Cussell incorporates skincare recommendations into every treatment plan.

Clinical treatments for perimenopausal skin at Rejuvenation Clinics of Australia

The following treatments are those most commonly recommended for clients experiencing perimenopausal skin changes. The right combination depends on your individual presentation – which is confirmed during consultation.

Collagen loss, fine lines, skin thinning

Actives to prioritise: Vitamin A (1%), growth factors, collagen peptides

Clinical treatments to consider: Bio remodelling, REJURAN®, RF needling, Fotona 4D, CO2 or Erbium laser, Ultraformer

Skin laxity, sagging, jowling

Actives to prioritise: Vitamin A, vitamin C, collagen peptides

Clinical treatments to consider: Ultraformer (HIFU), Fotona 4D, RF needling, volumising treatments

Pigmentation, uneven tone

Actives to prioritise: Vitamin B3 (10%), vitamin A, vitamin C

Clinical treatments to consider: Pico Rejuvenation, Fraxel, IPL Photo Rejuvenation, Deep Rejuvenation Plus

Barrier thinning, sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics, dual-weight HA

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Growth Factor treatments

Dryness, loss of glow

Actives to prioritise: Dual-weight HA, vitamins B and C, growth factors

Clinical treatments to consider: REJURAN®, bio remodelling, Glow Factor, Hydrafacial

Congestion, adult breakouts

Actives to prioritise: Vitamin A, vitamin B3, AHA/BHA exfoliation

Clinical treatments to consider: RF needling, Pico Rejuvenation, medical-grade peels, Cutera Laser Genesis, Hydrafacial

Crepey texture around eyes, neck

Actives to prioritise: Vitamin A, growth factors, collagen peptides

Clinical treatments to consider: SmoothEye, REJURAN® Eye, Fotona 4D, Fraxel, CO2 or Erbium laser

Slower healing, post-treatment sensitivity

Actives to prioritise: Vitamin B3, ceramides, pre/postbiotics

Clinical treatments to consider: Lower-intensity treatment sequencing, Phototherapy, growth factor support

SKIN QUALITY TREATMENTS

REJURAN® skin regeneration treatment

Rejuran uses polynucleotides derived from purified salmon DNA to support the skin’s natural repair environment at a cellular level. For perimenopausal skin specifically, it addresses the quality deterioration that oestrogen decline accelerates: skin thinning, fine dehydration lines, loss of elasticity, and crepey texture. REJURAN® Eye (Rejuran I) is a separately formulated option for the delicate periocular area.

Bio remodelling

Bio remodelling works within the deeper layers of the skin to stimulate collagen and elastin production — not by adding volume but by triggering the skin’s own regenerative response. It improves skin quality, laxity, and deep hydration across the face. Particularly effective for clients experiencing the accelerated skin thinning and laxity that characterises the early menopausal transition.

Glow Factor and Growth Factor treatments

RCA’s growth factor treatment range uses naturally occurring and synthetic growth factors to stimulate cellular renewal, improve hydration, and support the skin’s structural repair processes.

Particularly well suited to perimenopausal skin that is experiencing dullness, dehydration, and overall quality decline alongside other concerns.

LASER AND SKIN REJUVENATION

Fraxel laser

Fraxel stimulates skin cell turnover and collagen production across the face. Clinically proven to reduce fine lines, improve skin texture, and address pigmentation and sun damage simultaneously. Well suited to clients experiencing the combined texture and pigmentation changes that perimenopause accelerates. Involves a few days of redness. 

Pico Rejuvenation

Ultra-short pulse laser technology targeting pigmentation, skin rejuvenation, and uneven tone.

Particularly effective for the hormonally driven pigmentation changes common in perimenopause, with minimal downtime.

CO2 and Erbium laser resurfacing

For clients with more established fine lines, crepey skin texture, or significant cumulative sun damage, laser resurfacing produces meaningful structural change. CO2 delivers the most significant result but requires approximately one week of recovery per session. Full Erbium laser resurfacing offers a similar level of downtime with a gentler heat profile. For those wanting a lighter entry point, the Erbium Peel is a less intensive version that produces gradual improvement with less disruption to the skin surface – though multiple sessions are typically required. All three are available at Sydney CBD. .

Cutera Laser Genesis

A non-ablative treatment for skin quality, redness, enlarged pores, and overall texture refinement. No downtime. Particularly useful for the diffuse redness and skin quality decline that perimenopausal barrier changes can cause. Available at Sydney CBD. At Chatswood, Deep Rejuvenation using Fotona Frac3 delivers a comparable result for skin quality and texture refinement.

SKIN TIGHTENING AND LIFTING

Ultraformer – HIFU skin tightening

High-intensity focused ultrasound delivered to precise depths within the skin and underlying facial tissue – stimulating collagen and producing a meaningful lift and tightening effect that develops over two to three months and can last up to 18 months. Best suited to clients with visible laxity in the lower face, jowls, brow, and neck. A core treatment for the structural laxity that accelerates during perimenopause as oestrogen and progesterone decline.

RF Needling (Vivace and Fraxis Secret RF)

Combines microneedling with radiofrequency energy delivered simultaneously into the dermis, stimulating collagen and elastin production with progressive tightening that develops over two to three months. Addresses surface crepiness, early laxity, texture, and skin quality in the mid-to-lower face. Vivace available at Sydney CBD; Fraxis Secret RF at Chatswood.

Fotona 4D

A four-stage laser treatment that tightens, lifts, smooths, and rejuvenates in a single session by delivering energy both externally and internally via the oral mucosa. Stimulates collagen at multiple depths simultaneously. Effective for clients with visible laxity, deeper lines, and a tired or hollowed appearance — all common presentations in perimenopause. No downtime.

COSMETIC AESTHETICS

Volumising treatments

Volume loss from the mid-face fat pads is a direct consequence of the hormonal and structural changes of perimenopause.

Restoring lost volume with cosmetic aesthetic volumising treatments supports the facial architecture, reduces the appearance of descent-related lines, and creates a more rested and lifted appearance. All cosmetic aesthetic treatments at RCA are performed or supervised by our medical team, trained by Dr Cussell.

Wrinkle relaxing consultations

For expression lines driven by muscle movement – forehead lines, frown lines, crow’s feet – cosmetic aesthetic wrinkle relaxing consultations soften the appearance while preserving natural expression. Often combined with skin quality treatments for a more comprehensive result.

A note on maintenance – why consistency matters more in perimenopause

The ageing process does not pause between clinical treatment sessions. During perimenopause specifically, when the rate of collagen loss accelerates and oestrogen’s protective functions are withdrawing, the period between treatments matters more than it did in your 30s.

This is the argument for a maintenance mindset rather than a reactive one. Clients who combine consistent daily skincare with regular clinical treatment sessions – typically three times per year as a baseline – are maintaining a foundation that means each treatment session holds longer and requires less intervention to achieve the same result.

The alternative – treating when something becomes noticeably worse and then returning to a maintenance gap – means each subsequent session is correcting more lost ground rather than sustaining a plateau.

Dr Cussell’s approach at RCA is to help every client understand the maintenance trajectory from the beginning: what a course of treatment achieves, what sustains it, and what a realistic year of care looks like.

When to start – and why earlier is easier

The perimenopausal transition typically begins several years before the last menstrual period – often in the early-to-mid 40s. Progesterone begins declining before oestrogen, which means skin changes can start appearing earlier than many women expect – sometimes before cycle irregularity or other perimenopausal symptoms become obvious.
Clients who begin addressing perimenopausal skin changes early – before collagen loss, laxity, and pigmentation become established – can achieve meaningful results with a lighter programme and maintain them more easily. Those who come later can still achieve excellent outcomes, but the initial investment in correction is typically greater.
There is no universal right time. The right time is when the concern starts to affect your confidence and you are ready to have a conversation about what is driving it.

Frequently asked questions

What is the difference between perimenopause and menopause skin changes?
Perimenopause refers to the transition period before menopause – typically several years – when oestrogen, progesterone, and testosterone all begin to shift. Progesterone typically declines first and most erratically, which is why some skin changes begin before oestrogen decline becomes the dominant factor. Menopause is defined as 12 months after the final period, with post-menopause referring to the years that follow. Collagen loss accelerates significantly in the early post-menopausal period. Clinically, the approach to skin care is similar across both stages but is adjusted based on the degree of change and the specific concerns presenting.

Why has my skin become so sensitive when it never used to be?
Both oestrogen and progesterone support the skin barrier – oestrogen through ceramide synthesis, progesterone through its anti-inflammatory properties. As both decline and fluctuate, barrier integrity reduces and the skin becomes more reactive to ingredients, temperature changes, and environmental factors. This is a structural change, not a new skin type. The approach is to restore barrier function through targeted actives – ceramides, vitamin B3, pre and postbiotics – and to select clinical treatments that support rather than compromise the barrier while it is in transition.

I am getting pigmentation for the first time – is this related to perimenopause?
Yes. Oestrogen regulates melanin production. Fluctuating levels during perimenopause can trigger uneven melanin stimulation, particularly in areas of cumulative UV exposure. This type of pigmentation has a hormonal driver that standard sun-damage treatments may not address fully. Vitamin A accelerates cell turnover to bring pigmented cells to the surface faster; vitamin B3 inhibits the transfer of melanin from melanocytes to surrounding skin cells; Pico laser and Fraxel target pigmentation at depth. Your clinician will assess the type of pigmentation and recommend the most appropriate approach.

I am breaking out but also dry – is that normal during perimenopause?
Yes, and it is one of the more confusing presentations of perimenopausal skin. As oestrogen and progesterone decline, the relative androgenic effect on sebaceous glands increases – which can drive congestion and breakouts in some areas while the skin is simultaneously losing moisture and barrier function in others. This is why standard acne advice and standard dry-skin advice both fall short for perimenopausal skin. The right approach addresses both pathways at once – which is exactly what a clinical assessment at RCA will do.

Can cosmetic treatments help with the structural changes of perimenopause?
Yes – and for structural changes like collagen loss, laxity, and volume deflation, clinical treatments are the only interventions that reach the depth where these changes are occurring. Skincare actives support and maintain; clinical treatments correct and rebuild. The most effective approach combines both.

How many treatments will I need and how often?
This depends on the degree of concern and which treatments are recommended. Most skin quality treatments (REJURAN®, bio remodelling, Glow Factor) involve an initial course of two to three sessions followed by maintenance two to four times per year. Laser resurfacing typically involves a course of three sessions. HIFU skin tightening with Ultraformer is usually one to two sessions per year. Your clinician will give you a realistic course and maintenance plan during your consultation.

Is there anything I should be doing at home between sessions?
Yes – this is a significant part of the overall programme. The right skincare actives used consistently between sessions extend results, prepare the skin for treatment, and slow the rate of change between visits. Dr Cussell recommends a daily routine built around vitamin A, vitamin B3, vitamin C, dual-weight hydration, and growth factor support. For clients managing perimenopausal pigmentation specifically, a pigment inhibiting serum used between laser or skin rejuvenation sessions helps suppress melanin activity and maintain the clarity achieved in clinic. The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

The Rejuvaus range was developed by Dr Cussell to meet exactly this need for perimenopausal and post-menopausal skin.

Book your consultation at Rejuvenation Clinics of Australia

If your skin has changed during your 40s and you are not sure what is driving it or what to do about it, a consultation at RCA is the clearest starting point. Dr Garry Cussell and our clinical team – all trained by Dr Cussell directly – take a whole-face, whole-skin approach to every assessment. We will explain what is causing your specific concerns, what combination of actives and treatments is most likely to help, and what a realistic program of care looks like.

Your consultation is complimentary and completely obligation-free.

Book your complimentary consultation today.

Book online: rejuvaustralia.com.au/book-now/
Call us: 1300 88 99 35
Locations: Sydney CBD (254 George Street) | Chatswood (Suite 101, 443 Victoria Avenue)

Individual results vary. Treatment suitability is confirmed during consultation. All content produced in accordance with TGA advertising guidelines. Rejuvenation Clinics of Australia is a doctor-led cosmetic medicine clinic operating in Sydney since 2000. For information about skincare products, visit au.rejuvaus.com.

Scroll to Top